Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 435221 - 435240 out of 488799 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Sweden | (L01XE14) bosutinib | Bosulif® | 28, 500 mg , Blister, 28 tabletter (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | OrifarmAB |
Sweden | (L01XE27) ibrutinib | IMBRUVICA | 120, 140 mg , Burk, 120 kapslar | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagAB |
Sweden | (L01XE27) ibrutinib | IMBRUVICA | 90, 140 mg , Burk, 90 kapslar (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | OrifarmAB |
Sweden | (L01XE27) ibrutinib | IMBRUVICA | 28, 140 mg , Blister, 28 x 1 tabletter (endos) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagAB |
Sweden | (L01XE27) ibrutinib | IMBRUVICA | 28, 140 mg , Blister, 28 x 1 tabletter (endos) (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | OrifarmAB |
Sweden | (L01XE27) ibrutinib | IMBRUVICA | 28, 280 mg , Blister, 28 x 1 tabletter (endos) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagAB |
Sweden | (L01XE27) ibrutinib | IMBRUVICA | 28, 420 mg , Blister, 28 x 1 tabletter (endos) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagAB |
Sweden | (L01XE27) ibrutinib | IMBRUVICA | 28, 560 mg , Blister, 28 x 1 tabletter (endos) | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 100 mg , Blister, 21 kapslar | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 100 mg , Blister, 21 kapslar (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | MedartuumAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 100 mg , Blister, 21 kapslar (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AbacusMedicineA/S |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 100 mg , Blister, 21 kapslar (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 100 mg , Blister, 21 kapslar (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ParanovaLäkemedelAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 125 mg , Blister, 21 kapslar | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 125 mg , Blister, 21 kapslar (PD Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | MedartuumAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 125 mg , Blister, 21 kapslar (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | AbacusMedicineA/S |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 125 mg , Blister, 21 kapslar (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 125 mg , Blister, 21 kapslar (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ParanovaLäkemedelAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 75 mg , Blister, 21 kapslar (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAB |
Sweden | (L01XE33) palbociclib | IBRANCE | 21, 75 mg , Blister, 21 kapslar (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ParanovaLäkemedelAB |